Promomed Financial Statements (PRMD)
|
|
|
|
Report date
|
|
|
28.06.2024 |
28.06.2024 |
28.06.2024 |
23.04.2025 |
20.04.2026 |
|
20.04.2026 |
|
Currency
|
|
|
RUB |
RUB |
RUB |
RUB |
RUB |
|
RUB |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Annual report URL
|
|
|
|
|
|
|
|
|
|
|
Presentation URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
13.2 |
13.5 |
15.8 |
21.5 |
37.6 |
|
37.6 |
|
Operating Income, bln rub |
|
|
4.62 |
5.35 |
5.60 |
6.90 |
13.7 |
|
13.7 |
|
EBITDA, bln rub |
? |
|
5.03 |
5.95 |
6.28 |
8.23 |
15.3 |
|
15.3 |
|
Net profit, bln rub |
? |
|
3.38 |
3.97 |
2.97 |
2.86 |
7.04 |
|
7.04 |
|
|
OCF, bln rub |
? |
|
2.04 |
2.96 |
-1.19 |
0.093 |
0.267 |
|
0.267 |
|
CAPEX, bln rub |
? |
|
3.24 |
6.64 |
4.43 |
4.06 |
4.56 |
|
4.56 |
|
FCF, bln rub |
? |
|
-1.35 |
-3.68 |
-5.71 |
-4.17 |
-4.64 |
|
-4.64 |
|
|
Ordinary share dividend yield, %
|
|
|
|
|
|
0.0% |
0.0% |
|
0.0% |
|
Dividend payout ratio, %
|
|
|
0% |
0% |
0% |
0% |
0% |
|
0 |
|
|
OPEX, bln rub |
|
|
3.88 |
4.16 |
4.41 |
7.16 |
11.4 |
|
11.4 |
|
Cost of production, bln rub |
|
|
4.68 |
3.96 |
5.81 |
7.25 |
12.2 |
|
12.2 |
|
Amortization, bln rub |
|
|
0.4 |
0.6 |
1.0 |
1.1 |
1.4 |
|
1.4 |
|
Employment expenses, bln rub |
|
|
2.46 |
3.01 |
2.93 |
3.95 |
7.22 |
|
7.22 |
|
Interest expenses, bln rub |
|
|
0.400 |
0.740 |
1.59 |
2.90 |
4.17 |
|
4.17 |
|
|
Assets, bln rub |
|
|
16.3 |
25.9 |
34.8 |
53.1 |
71.0 |
|
71.0 |
|
Net Assets, bln rub |
? |
|
7.00 |
10.3 |
13.0 |
19.3 |
26.3 |
|
26.3 |
|
Debt, bln rub |
|
|
4.67 |
11.2 |
16.2 |
20.5 |
25.9 |
|
25.9 |
|
Cash, bln rub |
|
|
0.260 |
2.14 |
0.620 |
4.08 |
4.21 |
|
4.21 |
|
Net debt, bln rub |
|
|
4.41 |
9.03 |
15.6 |
16.4 |
21.7 |
|
21.7 |
|
|
Ordinary share price, rub |
|
|
|
|
|
355.3 |
406.0 |
|
413.4 |
|
Number of ordinary shares, mln |
|
|
|
212.5 |
200.0 |
212.5 |
212.5 |
|
212.5 |
|
Free Float, % |
|
|
|
|
|
|
7.00% |
|
7.00% |
|
|
Market cap, bln rub |
|
|
0.00 |
0.00 |
0.00 |
75.5 |
86.3 |
|
87.8 |
|
EV, bln rub |
? |
|
4.41 |
9.03 |
15.6 |
91.9 |
108.0 |
|
109.6 |
|
Book value, bln rub |
|
|
5.28 |
6.65 |
8.24 |
13.9 |
19.0 |
|
19.0 |
|
|
EPS, rub |
? |
|
|
18.7 |
14.9 |
13.4 |
33.1 |
|
33.1 |
|
FCF/share, rub |
|
|
|
-17.3 |
-28.6 |
-19.6 |
-21.8 |
|
-21.8 |
|
BV/share, rub |
|
|
|
31.3 |
41.2 |
65.2 |
89.3 |
|
89.3 |
|
|
EBITDA margin, % |
? |
|
38.0% |
44.1% |
39.7% |
38.4% |
40.6% |
|
40.6% |
|
Net margin, % |
? |
|
25.5% |
29.5% |
18.8% |
13.3% |
18.7% |
|
18.7% |
|
FCF yield, % |
? |
|
|
|
|
-5.5% |
-5.4% |
|
-5.3% |
|
ROE, % |
? |
|
48.3% |
38.4% |
22.9% |
14.8% |
26.8% |
|
26.8% |
|
ROA, % |
? |
|
20.7% |
15.3% |
8.5% |
5.4% |
9.9% |
|
9.9% |
|
|
P/E |
? |
|
0.00 |
0.00 |
0.00 |
26.4 |
12.3 |
|
12.5 |
|
P/FCF |
|
|
0.00 |
0.00 |
0.00 |
-18.1 |
-18.6 |
|
-18.9 |
|
P/S |
? |
|
0.00 |
0.00 |
0.00 |
3.52 |
2.30 |
|
2.34 |
|
P/BV |
? |
|
0.00 |
0.00 |
0.00 |
5.45 |
4.55 |
|
4.63 |
|
EV/EBITDA |
? |
|
0.88 |
1.52 |
2.48 |
11.2 |
7.07 |
|
7.17 |
|
Debt/EBITDA |
|
|
0.88 |
1.52 |
2.48 |
1.99 |
1.42 |
|
1.42 |
|
|
Employees, people |
|
|
|
|
|
2 215 |
2 826 |
|
2 826 |
|
Labour productivity, mln rub/person/year |
|
|
|
|
|
9.68 |
13.3 |
|
13.3 |
|
Expenses per employee, thousand rub |
|
|
|
|
|
1 781 |
2 553 |
|
2 553 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
24% |
49% |
28% |
19% |
12% |
|
12% |
|
| Promomed shareholders |
